Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

We recently published a list of Jim Cramer Discussed These 10 NASDAQ 100 Stocks Recently. In this article, we are going to ...

Learn about the types of providers who treat patients with age-related cognitive decline and dementia and how to get the most out of your initial visit.

Lilly’s solanezumab famously failed to produce significant results in early stage Alzheimer’s late last year, the latest in a long list of drugs that have come up short in trials. George ...

Novo Nordisk petitions the FDA to exclude liraglutide from the 503B Bulks List, citing safety risks, lack of clinical need, ...

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth quarter 2024 ...

A milestone review examining 1.4 million patients worldwide found that those who do not see the same doctor regularly are ...

The Shepherd’s Center of Greater Winston-Salem is offering a workshop for individuals turning 65 (as well as those who ...

That list includes gosuranemab ... at RBC Capital Markets has set a precedent that could allow more Alzheimer's drugs to reach the market. Lilly does seem to have been emboldened by the Aduhelm ...

The Himachal Pradesh cabinet on Thursday approved inclusion of families with no adult members between 18 and 59 years, headed by women or whose head has a disability of 50 per cent or more under the ...

Microsoft co-founder Bill Gates has a net worth of $160 billion. He has used his fortune to buy properties, cars, and donate ...

To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering ...